Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE
Sigurgeirsson B, Browning J, Tyring S, Szepietowski JC, Rivera-Diaz R, Effendy I, Bruin G, Paguet B, Fu R, Hampele I, Patekar M (2021)
Journal of the American Academy of Dermatology 85(3, Suppl.): AB154.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Sigurgeirsson, Bardur;
Browning, John;
Tyring, Stephen;
Szepietowski, Jacek C.;
Rivera-Diaz, Raquel;
Effendy, IsaakUniBi 
;
Bruin, Gerard;
Paguet, Bertrand;
Fu, Rong;
Hampele, Isabelle;
Patekar, Manmath
;
Bruin, Gerard;
Paguet, Bertrand;
Fu, Rong;
Hampele, Isabelle;
Patekar, ManmathErscheinungsjahr
2021
Serien- oder Zeitschriftentitel
Journal of the American Academy of Dermatology
Band
85
Ausgabe
3, Suppl.
Seite(n)
AB154
ISSN
0190-9622
eISSN
1097-6787
Page URI
https://pub.uni-bielefeld.de/record/2968742
Zitieren
Sigurgeirsson B, Browning J, Tyring S, et al. Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE. Journal of the American Academy of Dermatology. 2021;85(3, Suppl.):AB154.
Sigurgeirsson, B., Browning, J., Tyring, S., Szepietowski, J. C., Rivera-Diaz, R., Effendy, I., Bruin, G., et al. (2021). Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE. Journal of the American Academy of Dermatology, 85(3, Suppl.), AB154. https://doi.org/10.1016/j.jaad.2021.06.630
Sigurgeirsson, Bardur, Browning, John, Tyring, Stephen, Szepietowski, Jacek C., Rivera-Diaz, Raquel, Effendy, Isaak, Bruin, Gerard, et al. 2021. “Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE”, Journal of the American Academy of Dermatology, 85 (3, Suppl.): AB154.
Sigurgeirsson, B., Browning, J., Tyring, S., Szepietowski, J. C., Rivera-Diaz, R., Effendy, I., Bruin, G., Paguet, B., Fu, R., Hampele, I., et al. (2021). Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE. Journal of the American Academy of Dermatology 85, AB154.
Sigurgeirsson, B., et al., 2021. Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE. Journal of the American Academy of Dermatology, 85(3, Suppl.), p AB154.
B. Sigurgeirsson, et al., “Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE”, Journal of the American Academy of Dermatology, vol. 85, 2021, pp. AB154.
Sigurgeirsson, B., Browning, J., Tyring, S., Szepietowski, J.C., Rivera-Diaz, R., Effendy, I., Bruin, G., Paguet, B., Fu, R., Hampele, I., Patekar, M.: Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE. Journal of the American Academy of Dermatology. 85, AB154 (2021).
Sigurgeirsson, Bardur, Browning, John, Tyring, Stephen, Szepietowski, Jacek C., Rivera-Diaz, Raquel, Effendy, Isaak, Bruin, Gerard, Paguet, Bertrand, Fu, Rong, Hampele, Isabelle, and Patekar, Manmath. “Secukinumab administration by a 2 mL autoinjector demonstrates high efficacy with comparable safety and tolerability in adult patients with plaque psoriasis: 16-week results from MATURE”. Journal of the American Academy of Dermatology 85.3, Suppl. (2021): AB154.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar